Back to Search Start Over

Severity, predictors and clinical correlates of post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study

Authors :
Thomas Bahmer
Christoph Borzikowsky
Wolfgang Lieb
Anna Horn
Lilian Krist
Julia Fricke
Carmen Scheibenbogen
Klaus F. Rabe
Walter Maetzler
Corina Maetzler
Martin Laudien
Derk Frank
Sabrina Ballhausen
Anne Hermes
Olga Muljukov
Karl Georg Haeusler
Nour Eddine El Mokhtari
Martin Witzenrath
Jörg Janne Vehreschild
Dagmar Krefting
Daniel Pape
Felipe A. Montellano
Mirjam Kohls
Caroline Morbach
Stefan Störk
Jens-Peter Reese
Thomas Keil
Peter Heuschmann
Michael Krawczak
Stefan Schreiber
Source :
EClinicalMedicine, Vol 51, Iss , Pp 101549- (2022)
Publication Year :
2022
Publisher :
Elsevier, 2022.

Abstract

Summary: Background: Post-COVID syndrome (PCS) is an important sequela of COVID-19, characterised by symptom persistence for >3 months, post-acute symptom development, and worsening of pre-existing comorbidities. The causes and public health impact of PCS are still unclear, not least for the lack of efficient means to assess the presence and severity of PCS. Methods: COVIDOM is a population-based cohort study of polymerase chain reaction (PCR) confirmed cases of SARS-CoV-2 infection, recruited through public health authorities in three German regions (Kiel, Berlin, Würzburg) between November 15, 2020 and September 29, 2021. Main inclusion criteria were (i) a PCR confirmed SARS-CoV-2 infection and (ii) a period of at least 6 months between the infection and the visit to the COVIDOM study site. Other inclusion criteria were written informed consent and age ≥18 years. Key exclusion criterion was an acute reinfection with SARS-CoV-2. Study site visits included standardised interviews, in-depth examination, and biomaterial procurement. In sub-cohort Kiel-I, a PCS (severity) score was developed based upon 12 long-term symptom complexes. Two validation sub-cohorts (Würzburg/Berlin, Kiel-II) were used for PCS score replication and identification of clinically meaningful predictors. This study is registered at clinicaltrials.gov (NCT04679584) and at the German Registry for Clinical Studies (DRKS, DRKS00023742). Findings: In Kiel-I (n = 667, 57% women), 90% of participants had received outpatient treatment for acute COVID-19. Neurological ailments (61·5%), fatigue (57·1%), and sleep disturbance (57·0%) were the most frequent persisting symptoms at 6–12 months after infection. Across sub-cohorts (Würzburg/Berlin, n = 316, 52% women; Kiel-II, n = 459, 56% women), higher PCS scores were associated with lower health-related quality of life (EQ-5D-5L-VAS/-index: r = -0·54/ -0·56, all p

Details

Language :
English
ISSN :
25895370
Volume :
51
Issue :
101549-
Database :
Directory of Open Access Journals
Journal :
EClinicalMedicine
Publication Type :
Academic Journal
Accession number :
edsdoj.7641c051e8cd443b85c2da10ed36efbe
Document Type :
article
Full Text :
https://doi.org/10.1016/j.eclinm.2022.101549